Here, our results indicate that the brain seems to progressively loss the ability to desynchronize beta FC and that this process would be starting to become significant in preclinical stages, at least in participants with AD risk factors such as the presence of the APOE ε4 allele. The gene discussed is APOE; the disease is Alzheimer disease.